menu
    • menu

    Company profile for Axogen

    NEW Drugs in Dev: 2
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Axogen has over 10 years of experience as a leader in surgical solutions for peripheral nerve repair. Our solutions are used primarily by hand surgeons, reconstructive plastic surgeons, and oral and maxillofacial surgeons in a wide variety of nerve repair surgeries.Axogen will continue to work with leading surgeons and researchers to further translate research into solutions that improve the standard of care for patients with ...
    Axogen has over 10 years of experience as a leader in surgical solutions for peripheral nerve repair. Our solutions are used primarily by hand surgeons, reconstructive plastic surgeons, and oral and maxillofacial surgeons in a wide variety of nerve repair surgeries.Axogen will continue to work with leading surgeons and researchers to further translate research into solutions that improve the standard of care for patients with physical damage or discontinuity to peripheral nerves.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AxogenUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    13631 Progress Blvd, Suite 400 Alachua, FL 32615
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.axogeninc.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Axogen Reports 2025 Financial Results
    Axogen Reports 2025 Financial Results

    24 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/24/3243354/0/en/Axogen-Inc-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    24 Feb 2026
    Share Share
    Axogen to Participate in Multiple Upcoming Investor Conferences
    Axogen to Participate in Multiple Upcoming Investor Conferences

    17 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/17/3239062/0/en/Axogen-Inc-to-Participate-in-Multiple-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    17 Feb 2026
    Share Share
    Axogen to Report Q4, Full-Year 2025 Results on Feb. 24
    Axogen to Report Q4, Full-Year 2025 Results on Feb. 24

    10 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/10/3235160/0/en/Axogen-Inc-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-February-24-2026.html

    GLOBENEWSWIRE
    10 Feb 2026
    Share Share
    Axogen Announces Proposed Public Offering Of Common Stock
    Axogen Announces Proposed Public Offering Of Common Stock

    21 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/21/3223239/0/en/Axogen-Announces-Proposed-Public-Offering-of-Common-Stock.html

    GLOBENEWSWIRE
    21 Jan 2026
    Share Share
    Axogen Reports Preliminary Revenue For Q4 And Full-Year 2025
    Axogen Reports Preliminary Revenue For Q4 And Full-Year 2025

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3216692/0/en/Axogen-Inc-Reports-Preliminary-Unaudited-Revenue-for-Fourth-Quarter-and-Full-Year-2025.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    Axogen To Attend J.P. Morgan 2026 Healthcare Conference
    Axogen To Attend J.P. Morgan 2026 Healthcare Conference

    17 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/17/3206868/0/en/Axogen-Inc-to-Participate-in-the-J-P-Morgan-2026-Healthcare-Conference.html

    GLOBENEWSWIRE
    17 Dec 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search